Hisamitsu Pharmaceutical (Germany) Analysis

HPX Stock  EUR 25.20  0.20  0.80%   
Hisamitsu Pharmaceutical Co is fairly valued with Real Value of 25.25 and Hype Value of 25.2. The main objective of Hisamitsu Pharmaceutical stock analysis is to determine its intrinsic value, which is an estimate of what Hisamitsu Pharmaceutical Co is worth, separate from its market price. There are two main types of Hisamitsu Pharmaceutical's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Hisamitsu Pharmaceutical's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Hisamitsu Pharmaceutical's stock to identify patterns and trends that may indicate its future price movements.
The Hisamitsu Pharmaceutical stock is traded in Germany on Frankfurt Exchange, with the market opening at 08:00:00 and closing at 22:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Germany. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Hisamitsu Pharmaceutical's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hisamitsu Pharmaceutical Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Hisamitsu Stock Analysis Notes

About 26.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Hisamitsu Pharmaceutical last dividend was issued on the 27th of February 2023. The entity had 2:1 split on the 27th of June 2000. Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people. To learn more about Hisamitsu Pharmaceutical Co call Kazuhide Nakatomi at 81 3 5293 1720 or check out https://www.hisamitsu.co.jp.

Hisamitsu Pharmaceutical Investment Alerts

About 26.0% of the company shares are held by company insiders

Hisamitsu Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.02 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hisamitsu Pharmaceutical's market, we take the total number of its shares issued and multiply it by Hisamitsu Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Hisamitsu Profitablity

Hisamitsu Pharmaceutical's profitability indicators refer to fundamental financial ratios that showcase Hisamitsu Pharmaceutical's ability to generate income relative to its revenue or operating costs. If, let's say, Hisamitsu Pharmaceutical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Hisamitsu Pharmaceutical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Hisamitsu Pharmaceutical's profitability requires more research than a typical breakdown of Hisamitsu Pharmaceutical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09.

Technical Drivers

As of the 23rd of December, Hisamitsu Pharmaceutical retains the Risk Adjusted Performance of 0.0328, downside deviation of 2.21, and Market Risk Adjusted Performance of 0.1307. Hisamitsu Pharmaceutical technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Please check out Hisamitsu Pharmaceutical jensen alpha, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance to decide if Hisamitsu Pharmaceutical is priced fairly, providing market reflects its last-minute price of 25.2 per share.

Hisamitsu Pharmaceutical Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Hisamitsu Pharmaceutical middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Hisamitsu Pharmaceutical. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Hisamitsu Pharmaceutical Outstanding Bonds

Hisamitsu Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Hisamitsu Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Hisamitsu bonds can be classified according to their maturity, which is the date when Hisamitsu Pharmaceutical Co has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Hisamitsu Pharmaceutical Predictive Daily Indicators

Hisamitsu Pharmaceutical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Hisamitsu Pharmaceutical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Hisamitsu Pharmaceutical Forecast Models

Hisamitsu Pharmaceutical's time-series forecasting models are one of many Hisamitsu Pharmaceutical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Hisamitsu Pharmaceutical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Hisamitsu Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Hisamitsu Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Hisamitsu shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Hisamitsu Pharmaceutical. By using and applying Hisamitsu Stock analysis, traders can create a robust methodology for identifying Hisamitsu entry and exit points for their positions.
Hisamitsu Pharmaceutical Co., Inc. engages in the research and development, manufacture, purchase, and sale of pharmaceuticals in Japan. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. HISAMITSU PHARMA operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2770 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Hisamitsu Pharmaceutical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Manager Now

   

Portfolio Manager

State of the art Portfolio Manager to monitor and improve performance of your invested capital
All  Next Launch Module

Complementary Tools for Hisamitsu Stock analysis

When running Hisamitsu Pharmaceutical's price analysis, check to measure Hisamitsu Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hisamitsu Pharmaceutical is operating at the current time. Most of Hisamitsu Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Hisamitsu Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hisamitsu Pharmaceutical's price. Additionally, you may evaluate how the addition of Hisamitsu Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Global Correlations
Find global opportunities by holding instruments from different markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios